ELAHERE ratings & reviews

Mirvetuximab Soravtansine
Company: Academic
Brand: ELAHERE
Drug class: Antineoplastic and Immunomodulating Agents
+3 more
Antineoplastic and Immunomodulating Agents, Antineoplastics, Antineoplastic Drug Conjugates, Antineoplastic Monoclonal Antibody-Drug Conjugates (ADCs)

Sermo AI Overview

  • Users rate ELAHERE with a moderate overall satisfaction score of 3.6 out of 5, indicating mixed experiences regarding its benefits and effectiveness in treatment.
  • ELAHERE has shown effectiveness in treating platinum-resistant ovarian cancer, especially in patients who test positive for Folate receptor alpha, highlighting its targeted capability.
  • Access to ELAHERE is notably challenging, with an accessibility rating of just 1 out of 5, which may hinder patients' ability to obtain this important medication.
Based on insights from Sermo’s triple verified physicians

Description

MIRVETUXIMAB SORAVTANSINE (MIR ve TUX i mab SOE rav TAN seen) treats ovarian cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

Dosage & Administration

How should I use this medication?

This medication is injected into a vein. It is given by your care team in a hospital or clinic setting. A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time. Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Dry cough, shortness of breath or trouble breathing -Dry eyes -Eye pain, redness, irritation, or discharge with blurry or decreased vision -Infection—fever, chills, cough, or sore throat -Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded -Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue -Low magnesium level—muscle pain or cramps, unusual weakness or fatigue, fast or irregular heartbeat, tremors -Low red blood cell level—unusual weakness or fatigue, dizziness, headache, trouble breathing -Pain, tingling, or numbness in the hands or feet -Sensitivity to light Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome): -Constipation -Diarrhea -Nausea -Stomach pain

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Eye disease -Liver disease -Lung disease -Tingling of the fingers or toes or other nerve disorder -Vision problems -Wear contact lenses -An unusual or allergic reaction to mirvetuximab soravtansine, other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breast-feeding

What may interact with this medication?

Interactions have not been studied. Some medications may affect this one. Tell your care team all of the medications you take.

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

This medication may make you feel generally unwell. This is not uncommon as chemotherapy can affect healthy cells as well as cancer cells. Report any side effects. Continue your course of treatment even though you feel ill unless your care team tells you to stop. This medication can cause serious infusion reactions. To reduce the risk, your care team may give you other medications to take before receiving this one. Be sure to follow the directions from your care team. This medication may cause dry eyes. Lubricating eye drops may help. See your care team if the problem does not go away or is severe. Your vision may be tested before and during use of this medication. Tell your care team right away if you have any change in your eyesight. This medication may increase your risk of getting an infection. Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu. Do not treat yourself. Try to avoid being around people who are sick. Avoid taking medications that contain aspirin, acetaminophen, ibuprofen, naproxen, or ketoprofen unless instructed by your care team. These medications may hide a fever. Talk to your care team if you wish to become pregnant or think you might be pregnant. Serious birth defects can occur if you take this medication during pregnancy. A negative pregnancy test is required before starting this medication. Contraception is recommended while taking this medication and for 7 months after the last dose. Your care team can help you find the option that works best for you. Do not breast-feed while taking this medication and for 1 month after stopping it.

What are the most serious risks of this medication?

This medication can cause serious eye problems.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence